Colgate-Palmolive
CL
Colgate-Palmolive (CL) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.99
- EPS estimate
- $0.95
- EPS surprise
- +4.54%
- Revenue surprise
- +0.09%
- Revenue
- $5.4B
- Revenue estimate
- $5.4B
- Reported
- Jul 31, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $0.95 | $0.99 | +4.54% | $5.4B | SEC |
| Q1 2026 | May 1, 2026 | $0.94 | $0.97 | +2.83% | $5.3B | SEC |
| Q4 2025 | Jan 30, 2026 | $0.91 | $0.95 | +4.19% | $5.2B | SEC |
| Q3 2025 | Oct 31, 2025 | $0.89 | $0.91 | +2.35% | $5.1B | SEC |
| Q2 2025 | Aug 1, 2025 | $0.90 | $0.92 | +2.54% | $5.1B | SEC |
| Q1 2025 | Apr 25, 2025 | $0.86 | $0.91 | +6.32% | $4.9B | SEC |
| Q4 2024 | Jan 31, 2025 | $0.89 | $0.91 | +2.28% | $4.9B | SEC |
| Q3 2024 | Oct 25, 2024 | $0.89 | $0.91 | +2.81% | $5.0B | SEC |
| Q2 2024 | Jul 26, 2024 | $0.87 | $0.91 | +4.74% | $5.1B | SEC |
| Q1 2024 | Apr 26, 2024 | $0.81 | $0.86 | +5.81% | $5.1B | SEC |
| Q4 2023 | Jan 26, 2024 | $0.85 | $0.87 | +2.16% | $5.0B | SEC |
| Q3 2023 | Oct 27, 2023 | $0.80 | $0.86 | +7.26% | $4.9B | SEC |
| Q2 2023 | Jul 28, 2023 | $0.75 | $0.77 | +3.24% | $4.8B | SEC |
| Q1 2023 | Apr 28, 2023 | $0.70 | $0.73 | +4.27% | $4.8B | SEC |
| Q4 2022 | Jan 27, 2023 | $0.76 | $0.77 | +0.72% | $4.6B | SEC |
| Q3 2022 | Oct 28, 2022 | $0.73 | $0.74 | +1.08% | $4.5B | — |
| Q2 2022 | Jul 29, 2022 | $0.71 | $0.72 | +1.48% | $4.5B | — |
| Q1 2022 | Apr 29, 2022 | $0.74 | $0.74 | −0.60% | $4.4B | — |
| Q4 2021 | Jan 28, 2022 | $0.79 | $0.79 | +0.43% | $4.4B | — |
| Q3 2021 | Oct 29, 2021 | $0.80 | $0.81 | +1.84% | $4.4B | — |
Quarterly revenue
Frequently asked questions
When did Colgate-Palmolive (CL) last report earnings?
Colgate-Palmolive last reported on Jul 31, 2026, covering fiscal Q2 2026.
Did CL beat earnings estimates?
Yes. Colgate-Palmolive reported EPS of $0.99 for Q2 2026 against a $0.95 estimate — a 4.54% beat.
How much revenue did CL report last quarter?
Colgate-Palmolive reported $5.4B in revenue for Q2 2026, against a consensus estimate of $5.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.